UDP-galactofuranose Precursor Required for Formation of the Lipopolysaccharide O Antigen of Klebsiella pneumoniae Serotype O1 Is Synthesized by the Product of the rfbDKPO1 Gene*

(Received for publication, September 16, 1996, and in revised form, November 11, 1996)

Reinhard Köplin Dagger , Jean-Robert Brisson § and Chris Whitfield Dagger

From the Canadian Bacterial Diseases Network, Dagger  Department of Microbiology, University of Guelph, Guelph, Ontario, Canada, N1G 2W1, and the § Institute for Biological Sciences, National Research Council, Ottawa, Ontario, Canada, K1A 0R6

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
Note Added in Proof
REFERENCES


ABSTRACT

The O-side-chain polysaccharide in the lipopolysaccharide of Klebsiella pneumoniae O1 is based on a backbone structure of repeat units of [right-arrow3)-beta -D-Galf-(1right-arrow3)-alpha -D-Galp-(1right-arrow]; this structure is termed D-galactan I. The rfb (O-antigen biosynthesis) gene cluster directs the synthesis of D-galactan I and consists of six genes termed rfbA-FKPO1. In this paper we show that rfbDKPO1 encodes a UDP-galactopyranose mutase (NAD(P)H-requiring) (EC 5.4.99.9), which forms uridine 5'-(trihydrogen diphosphate) P'-alpha -D-galactofuranosyl ester (UDP-Galf), the biosynthetic precursor of galactofuranosyl residues. The deduced amino acid sequence of rfbDKPO1 shows 85% and 37.5% identity to the rfbDKPO8 gene of K. pneumoniae serotype O8 and the glf gene of Escherichia coli, respectively. The molecular mass of the purified RfbDKPO1 enzyme is 45 kDa as determined by SDS-polyacrylamide gel electrophoresis, while gel filtration revealed a molecular mass of 92 kDa, suggesting a dimeric structure for the native protein. The rfbDKPO1 gene product interconverts uridine 5'-(trihydrogen diphosphate) P'-alpha -D-galactopyranosyl ester (UDP-Galp) and UDP-Galf. Unlike Glf, RfbDKPO1 showed a requirement for NADH or NADPH, which could not be replaced by NAD or NADP. RfbDKPO1 was used to synthesize milligram quantities of UDP-Galf, allowing this compound to be purified and fully characterized in an intact form for the first time. The structure of UDP-Galf was proven by NMR spectroscopy.


INTRODUCTION

Lipopolysaccharide (LPS)1 is a major component of the outer membrane of Gram-negative bacteria. In enteric bacteria, the LPS molecule comprises a hydrophobic lipid A portion, which forms the outer leaflet of the outer membrane, a core oligosaccharide, and an O-side-chain polysaccharide. The O polysaccharide varies in structure from strain to strain, giving rise to unique antigenic epitopes (O antigens). In the genus Klebsiella, there exists a family of structurally related galactose-containing O polysaccharides. These are based on a backbone structure consisting of a disaccharide O-repeat unit [right-arrow3)-beta -D-Galf-(1right-arrow3)-alpha -D-Galp-(1right-arrow] known as D-galactan I (1). Variations in O antigens arise from addition of side-chain alpha -D-Galp (2) and O-acetyl (2, 3) residues, or by addition of domains of varying structure (1, 4-6). Galactofuranosyl residues are present in a growing number of LPS O antigens e.g. in strains of Serratia marcescens (7, 8), Shigella dysinteriae (9), Shigella boydii (10), Escherichia coli (11), Pasteurella hemolytica (12), Hemophilus pleuropneumoniae (13), and Actinobacillus pleuropneumoniae (14). The T1-antigen polysaccharide of Salmonella friedenau (15) and a variety of capsular or extracellular polysaccharides from both Gram-negative and Gram-positive bacteria (e.g. Refs. 16-20) contain Galf. Galactofuranosyl residues are a central component in the mycolyl-arabinogalactan complex, which is characteristic of the cell walls of mycobacteria (21) and the related genera Nocardia and Rhodococcus (22), in the lipoglycan of Mycoplasma mycoides (23), in the paracrystalline S-layer glycoprotein of Clostridium thermohydrosulfuricum S102-70 (24), and in the cellulosome glycoproteins of Clostridium thermocellum (25) and Bacteroides cellulosolvens (26). In eukaryotes, galactofuranosyl residues are found in the lipophosphoglycan of Leishmania donovani (27), Leishmania major (28), and Leishmania mexicana (29), in the N-linked glycoproteins of Crithidia spp. (30), and in the lipopeptidophosphoglycan of Trypanosoma cruzi (31). A variety of fungal cell surface glycans, glycolipids and glycoproteins contain Galf residues in Penicillium spp. (32-34), Aspergillus spp. (35), Neurospora crassa (36), and Histoplasma capsulatum (37). Many of these microorganisms are important pathogens, and, for some, current therapies are limited. This observation, together with the absence of Galf residues in human glycoconjugates has fueled interest in the potential of generating novel therapeutic compounds directed against reactions involved in the formation of Galf precursors (38).

In the prototype system in K. pneumoniae O1, D-galactan I biosynthesis is directed by enzymes encoded by six genes in the chromosomal rfb locus. The polymer is synthesized in the cytoplasm by RfbCDEF activities and is then transported across the plasma membrane by a process involving an ATP-binding cassette (ABC-2) transporter, where RfbA is the transmembrane component and RfbB contains the consensus ATP-binding motifs (39). The synthesis of D-galactan I is initiated on a "primer" comprising undecaprenyl pyrophosphoryl N-acetylglucosamine. The primer is formed by the activity of the Rfe protein which appears to be an UDP-GlcNAc:undecaprenylphosphate GlcNAc-1-phosphate transferase (40). RfbF is a bifunctional galactosyl transferase, which forms the disaccharide [right-arrow3)-beta -D-Galf-(1right-arrow3)-alpha -D-Galp-1(right-arrow] on the primer (41). The details of the subsequent polymerization reaction(s) have not yet been resolved.

The precursor for Galp residues is UDP-Galp (42), formed by the action of UDP-galactose 4-epimerase, encoded by the galE gene in the galactose operon (43). Early studies on the biosynthesis of the T1 antigen in S. enterica serovar Typhimurium (44, 45) suggested that Galf precursors were derived from Galp at the level of UDP-linked sugars. The Galf precursor for a galactofuranosyl-containing polysaccharide in Penicillium charlesii was also proposed to be a UDP-linked derivative (46). More recently, the product of orf6, an enzyme encoded by the cryptic rfb locus in E. coli K-12 strains (47), was shown to have UDP-galactopyranose mutase (EC 5.4.99.9) activity, capable of the reversible formation of UDP-Galf from UDP-Galp (48). The product UDP-Galf was predicted from degradation products and this compound has not been isolated and fully characterized in an intact state.

This paper reports the cloning, expression, and purification of RfbDKPO1 from K. pneumoniae O1. We show that the enzyme has UDP-galactopyranose mutase activity but differs in several important aspects from the homologue from E. coli K-12. In addition, we report the isolation and first complete chemical characterization of intact UDP-Galf.


EXPERIMENTAL PROCEDURES

Bacterial Strains, Plasmids, and Growth Conditions

The strains and plasmids used in this study are given in Table I. Strains were grown in Luria-Bertani (LB) medium containing the appropriate antibiotics. Antibiotics were used at the following concentrations: ampicillin, 100 µg/ml; kanamycin, 50 µg/ml; chloramphenicol, 50 µg/ml.

Table I.

Bacterial strains and plasmids


Strain/plasmid Relevant characteristic(s) Source or reference

E. coli
  DH5alpha K-12 F- phi 80d lacZDelta endA1 recA1 hsdR17(rK-mK-) supE44 thi-1 gyrA96 relA1 Delta (lacZYA-argF)U196 49
  SØ874 K-12 lacZ trp Delta (sbcB-rfb) upp rel rpsL 69
  CWG287 K-12 lacZ trp Delta (sbcB-rfb) upp rel rpsL lambda DE3 This work
  CWG288 K-12 lacZ trp Delta (sbcB-rfb) upp rel rpsL lambda DE3 galE::Tn10 This work
Plasmids
  pBBR1 Broad host range cloning vector; CmR 70
  pET30a(+) T7 expression vector; KmR Novagen
  pWQ5 pBluescript KS(+) derivative containing the rfbKPO1 region; ApR 39
  pWQ66 rfbDKPO1 cloned as a NdeI/HindIII fragment into pET30 a(+) This work
  pWQ70 pWQ71 containing a 630-base pair in-frame deletion in rfbDKPO1 This work
  pWQ71 pBBR1 derivative containing the rfbKPO1 region; CmR This work

DNA Manipulation and Analysis

Restriction endonuclease digestion, ligation, and transformation were performed essentially as described by Sambrook et al. (49). Plasmid DNA preparations were made with QIAGEN Inc. columns according to the manufacturer's instructions. CLUSTAL W was used for the multiple alignment (50) using default parameters.

Plasmid Construction

pWQ71 was constructed by cloning a XbaI-HindIII fragment of pWQ5 containing the complete rfbKPO1 gene cluster into pBBR1MCS. In order to delete an internal region in rfbDKPO1, plasmid pWQ5 was mutagenized using a Transformer site-directed mutagenesis kit (Clontech), which is based on the method of Deng and Nickoloff (51). The 5'-phosphorylated primers 5'-CAT GTT TAT <UNL>GGA</UNL> <UNL>TCC</UNL> CAT ATT TTC C-3' and 5'-GAT TAC CAG <UNL>GGA</UNL> <UNL>TCC</UNL> GCA GTG ATG-3' were used to introduce a BamHI site (underlined) in the 5' and 3'-regions of rfbDKPO1, respectively. The 5'-phosphorylated selection primer 5'-GCC TTT TTA CTT AGT AAT CCT AAA G-3' alters a unique CelII site in rfbFKPO1 and was used as selection primer. Digestion of this construct with BamHI, followed by religation, resulted in an in-frame deletion of 630 base pairs. The rfbKPO1 gene cluster containing the rfbDKPO1 deletion was subsequently cloned into pBBR1MCS on a XbaI-HindIII fragment, resulting in pWQ70. To clone the rfbDKP01 open reading frame, plasmid pWQ5 was mutagenized using the Transformer site-directed mutagenesis kit (Clontech) in order to introduce NdeI and HindIII sites overlapping with the start and stop codons of rfbDKPO1, respectively. The NdeI-HindIII fragment containing the entire rfbDKPO1 open reading frame was cloned into pET30a(+) (Novagen), resulting in pWQ66.

SDS-PAGE of LPS

LPS samples were routinely prepared by the SDS-proteinase K lysate method (52). Samples were analyzed by SDS-PAGE according to the conditions described by Lesse et al. (53), and gels were silver-stained by the method of Tsai and Frasch (54).

Overexpression of RfbDKPO1

An overnight culture of E. coli CWG288 (pWQ66) was diluted 1:200 into fresh medium (LB, 250 mM sorbitol, 50 µg/ml kanamycin) and grown to an A580 of 0.5. Galactose and isopropyl-1-thio-beta -D-galactopyranoside were added to a final concentration of 10 mM and 0.4 mM, respectively. The cells were then grown for an additional 3 h at 37 °C, collected by centrifugation at 7,800 × g, 4 °C for 10 min, and stored at -70 °C in aliquots of 1 g of wet cell paste.

Extraction of Nucleotide Sugars

For the extraction of sugar nucleotides, 1 g of wet cell paste was resuspended in 5 ml of 75% ethanol and incubated at 100 °C for 10 min. Cell debris was removed by centrifugation (20,000 × g, 10 min) and reextracted with another 5 ml of 75% ethanol. The samples were evaporated to dryness and redissolved in a small volume of water. Insoluble material was removed by centrifugation.

Purification of the RfbDKPO1 Protein of K. pneumoniae Serotype O1

Wet cell paste (1 g) was resuspended in 9 ml of 50 mM HEPES, pH 7.0, 1 mM phenylmethylsulfonyl fluoride, 0.1 mM dithiothreitol, and the suspension was disrupted by sonication. Cell debris was removed by centrifugation at 20,000 × g for 30 min, followed by ultracentrifugation at 100,000 × g for 1 h. The 100,000 × g supernatant was further fractionated by ammonium sulfate precipitation at 4 °C. The fraction between 55% and 75% saturation contained the RfbDKPO1 protein and was dialyzed against 50 mM HEPES pH 7.0 overnight, and then concentrated to ~ 0.5 ml using a ultrafiltration cartridge (Centriplus 30, Amicon). RfbD was further purified by dye-ligand affinity chromatography on 5-ml columns of Reactive Green 5-agarose (Sigma) and Cibacron Blue 3GA-agarose (Sigma) at room temperature. The concentrated protein fraction was applied to the Reactive Green 5-column preequilibrated with 50 mM HEPES pH 7.0 and washed with 25 ml of 50 mM HEPES pH 7.0. This column bound the majority of applied protein, while most of the RfbDKPO1 protein was not retained under this conditions. The unbound fraction was subsequently applied to a 5-ml column of Cibacron Blue 3GA-agarose equilibrated with 50 mM HEPES pH 7.0, washed with 25 ml of 50 mM HEPES pH 7.0. The rfbDKP01 protein was eluted with 10 ml of 1 mM UDP-Galp in 50 mM HEPES pH 7.0. Residual contaminating proteins were removed by anion exchange chromatography on MonoQ at room temperature, using a linear sodium chloride gradient (0-300 mM) in 50 mM HEPES pH 7.0.

Enzyme Reactions

UDP-galactopyranose mutase reactions were performed at 37 °C for 30 min. The reaction mixture consisted in a total volume of 100 µl: 50 mM HEPES pH 7.0, 1 mM UDP-Galp (UDP-Galf), 2 mM NADH or NADPH, and variable amounts of UDP-galactopyranose mutase (NAD(P)H-requiring). The reaction products were analyzed by HPAEC on CarboPac PA1 (Dionex).

HPLC Analysis

Sugar nucleotides were analyzed on a CarboPac PA1 column (4 × 250 mm) according to the method of Palmieri et al. (55) with minor modifications. Sugar nucleotides were separated using a linear ammonium acetate (pH 7.0) gradient from 200 to 500 mM in 50 min at a flow rate of 0.6 ml/min. UDP-sugars were detected at 262 nm. For the purification of larger quantities of UDP-Galf, a CarboPac PA1 column (9 × 250 mm) operated at a flow rate of 3 ml/min was used. Separated compounds were recovered by lyophilization.

NMR Analysis

The 1H, 13C, and 31P spectra were recorded on a Bruker AMX-600 spectrometer, at 285 K using a 5-mm broadband tunable probe. The sample was prepared from 0.5 mg of UDP-Galf in ammonium acetate buffer, lyophilized, and redissolved in 0.6 ml of 10 mM potassium phosphate buffer (pH 7.2), containing 0.5 mM EDTA. The pH of the sample dropped below 6; therefore, additional K2HPO4 was immediately added to adjust the pH to 6.8. The sample was then lyophilized and redissolved in 0.6 ml of D2O and transferred to a 5-mm NMR tube. Acetone was added to the sample to provide the internal proton chemical shift reference at 2.225 ppm. The methyl resonance of an external acetone in D2O, set at 31.07 ppm, was used for the 13C chemical shift reference. The chemical shift reference for 31P was that of external phosphoric acid (25%) in D2O set at 0.0 ppm. All of the experiments were carried out without sample spinning and with the standard software and pulse programs provided by Bruker. The J(H,H) and J(P,H) coupling constants were measured directly from the one-dimensional 1H or 31P spectra processed with a digital resolution of 0.2 Hz/point.

The 1H spectrum of 256 scans was recorded with presaturation of the HOD resonance at 4.945 ppm. The 13C spectrum with proton decoupling was recorded overnight with 50,000 scans. The 31P spectrum of 4000 scans was recorded without proton decoupling. The two-dimensional homonuclear magnitude COSY, phase-sensitive TOCSY, 1H-31P HMQC, 1H-13C HMQC experiments were recorded and processed as described previously (56). The one-dimensional TOCSY z-filtered spectra of 2000 scans was performed as described previously (57).


RESULTS

The K. pneumoniae Serotype O1 rfbDKPO1 Gene Encodes a Functional Homologue of Glf of E. coli K-12

The rfbKPO1 gene cluster that directs formation of D-galactan I (39, 42) consists of six genes termed rfbA-F. The rfbDKPO1 open reading frame comprises 1152 nucleotides. No consensus ribosome binding site was found upstream of the ATG initiation codon of rfbDKPO1. The TGA stop codon of rfbDKPO1 overlaps with the ATG initiation codon of rfbEKPO1, suggesting translational coupling. The predicted translational product of rfbDKPO1 is a 384-amino acid protein with a molecular weight of 44,454 and a theoretical pI of 6.06. The N-terminal region between Lys-5 and Asp-33 contains a signature for an ADP-binding beta alpha beta -fold involved in FAD or NAD binding (58). The sequence deviates only at Gly-19 from the fingerprint. Consequently, a BLAST search (59) revealed striking similarities of the N terminus of rfbDKPO1 to flavin-containing oxidases and dehydrogenases. Across the entire predicted polypeptide, 85% and 37.5% identity were found to the rfbDKPO8 gene of K. pneumoniae serotype O8 (also comprising D-galactan I (3, 60) and the glf (orf6) gene of E. coli K-12, respectively (Fig. 1).


Fig. 1. Multiple alignment of the deduced amino-acid sequences of rfbDKPO1, rfbDKPO8, and glf (orf6) of E. coli K-12. The alignment was derived using CLUSTAL W with default parameters. Identical residues are marked by asterisks; similar residues are marked by periods.
[View Larger Version of this Image (75K GIF file)]


Direct evidence that rfbDKPO1 encodes a Glf homologue was obtained from complementation experiments. The rfbKPO1 gene cluster was cloned into pBBR1MCS resulting in pWQ71. Site-directed mutagenesis was used to generate plasmid pWQ70, which contains an in-frame deletion of 630 base pairs in the rfbDKPO1 gene of the D-galactan I gene cluster. A physical map of the DNA fragments cloned into pWQ70 or pWQ71 is given in Fig. 2. The LPS phenotypes conferred by these plasmids were analyzed by SDS-PAGE in DH5alpha and a derivative of strain SØ874 (CWG287). The glf gene, located in the cryptic E. coli K-12 rfb region (47, 61), is deleted in E. coli SØ874. The LPS of DH5alpha or CWG287 both containing the complete cluster (pWQ71) showed a ladder of smooth LPS (S-LPS) (Fig. 3). Deletion of the internal region of rfbDKPO1 in pWQ70 resulted in no phenotypic alterations in DH5alpha , while in CWG287 the synthesis of S-LPS was completely abolished (Fig. 3), suggesting that a gene of the cryptic rfb cluster of E. coli K-12, most likely glf, is functionally equivalent to rfbD KPO1.


Fig. 2. Structure and organization of the rfb gene cluster from K. pneumoniae serotype O1. A, partial restriction map of the K. pneumoniae rfbKPO1 cluster, cloned into pBBR1MCS (pWQ71). B, structure of the rfbKPO1 cluster containing a 630-base pair in-frame deletion in rfbDKPO1 (pWQ70). The location and orientation of the rfbA-FKPO1 genes are indicated by arrows below the restriction map. Only insert DNA is shown.
[View Larger Version of this Image (14K GIF file)]



Fig. 3. Silver-stained SDS-PAGE gel showing the LPS phenotype of a rfbDKPO1 deletion-derivative (pWQ70) in E. coli DH5alpha and CWG287. Synthesis of D-galactan I results in high molecular weight ladders of S-LPS. The rfbDKP01 deficiency is complemented by a chromosomal locus in E. coli DH5alpha , or by supplying pWQ66 in trans. Plasmid pWQ66 carries a functional copy of rfbDKP01.
[View Larger Version of this Image (52K GIF file)]


An E. coli K-12 Delta rfb Strain Overexpressing RfbDKPO1 Accumulates UDP-Galp and a Novel Galactose-containing UDP Derivative

The function of RfbDKPO1 was further addressed by analyzing the UDP-sugars synthesized in vivo. In order to achieve high level expression of RfbDKPO1, a NdeI and a HindIII site overlapping with the start and stop codon of rfbDKPO1, respectively, were introduced by site-directed mutagenesis. The NdeI-HindIII fragment containing only the rfbDKPO1 open reading frame was cloned into the T7 expression vector pET30a(+), resulting in pWQ66. The functionality of the rfbDKPO1 gene was proven by complementation of CWG287 (pWQ70). When pWQ66 was transformed into CWG287 (pWQ70), the synthesis of S-LPS was restored, even without isopropyl-1-thio-beta -D-galactopyranoside induction (Fig. 3). To avoid further metabolism of in vivo synthesized UDP-Galp or UDP-Galf, CWG288 (E. coli K-12 Delta rfb lambda DE3 galE) was constructed as a galE derivative of CWG287. Additionally, sorbitol, which has been reported to suppress elevated levels of UDP-sugar hydrolase activity as a result of UDP-galactose accumulation (62), was added to the medium to avoid enzymatic degradation. Nucleotide sugars were extracted from CWG288 (pWQ66) and from the control strain CWG288 (pET30a(+)), and extracts were analyzed by HPAEC. From Fig. 4 it can be seen that both strains accumulated UDP-Galp (retention time 34.5 min), while an additional peak (p37) with a retention time of 37.5 min was unique to extracts of CWG288 (pWQ66). In experiments using [1-14C]galactose, p37 was found to contain about 5% of the radioactivity, with the remaining 95% confined to the UDP-Galp peak (data not shown), suggesting that p37 is a novel galactose-containing sugar nucleotide formed by the activity of RfbDKPO1.


Fig. 4. HPLC elution profile of nucleotide sugars extracted from CWG288 (pWQ66) and CWG288 (pET30a(+)). Nucleotide sugars were extracted with boiling ethanol, evaporated to dryness, redissolved in water, and analyzed by HPAEC on a CarboPac PA1 using a linear ammonium acetate gradient from 200-500 mM. Only the relevant parts of the elution profiles are shown.
[View Larger Version of this Image (10K GIF file)]


Purification and Characterization of the RfbDKPO1 Protein

In order to unequivocally determine the function of RfbDKPO1 and the nature of p37, the RfbDKPO1 protein was purified to homogeneity from CWG288 (pWQ66) by ammonium sulfate precipitation, dye-ligand affinity chromatography, and anion exchange chromatography as described in detail under "Experimental Procedures." The protein was homogeneous as judged by SDS-PAGE (Fig. 5). The molecular mass of 45,000 Da of the denatured polypeptide determined by SDS-PAGE is in good agreement with the predicted molecular weight of 44,454. However, gel filtration on Superose 12 revealed a molecular weight of 92,000, suggesting a dimeric structure for the native protein (data not shown).


Fig. 5. SDS-PAGE analysis of the RfbDKPO1 purification. Lane 1, 100,000 × g supernatant; lane 2, ammonium sulfate precipitate; lane 3, RfbDKPO1 eluted from Cibacron 3FG-agarose with 1 mM UDP-Galp; lane 4, concentrated fraction from MonoQ anion-exchange chromatography. The positions of the SDS-PAGE marker proteins phosphorylase b (97.4 kDa), serum albumin (66.2 kDa), ovalbumin (45.0 kDa), carbonic anhydrase (31.0 kDa), trypsin inhibitor (21.5 kDa), and lysozyme (14.4 kDa) are indicated.
[View Larger Version of this Image (59K GIF file)]


An in vitro assay was used to gain more information on the RfbDKPO1-mediated reaction. The enzyme reaction was carried out in a total volume of 100 µl, and the reaction products obtained after incubation at 37 °C for 30 min were analyzed by HPAEC on a CarboPac PA1. The enzyme showed an absolute requirement for NADH or NADPH (data not shown). Under these reaction conditions, a peak well separated from UDP-Galp or UDP-Glc with the same retention time as p37 was obtained (Fig. 6B). In all experiments about 5% of UDP-Galp was converted to p37. No reaction could be seen in assays lacking the cofactor, or in assays containing NAD or NADP. When pooled p37 was used as substrate in the enzyme assay, ~95% was converted back to UDP-Galp (Fig. 6C), while no reaction was observed in assays lacking a cofactor or in assays with NAD or NADP (data not shown). Other than the cofactor requirements, these data are in agreement with the data described for Glf of E. coli (48) and further support the conclusion that p37 indeed is UDP-Galf.


Fig. 6. HPLC profiles of purified UDP-Galf and the reaction products of the UDP-galactopyranose mutase assays. A, HPLC profile of a mixture of UMP, UDP-Galp, and UDP-Glc. B, reaction products obtained with UDP-Galp as substrate. C, reaction products obtained using UDP-Galf as substrate. D, purified UDP-Galf.
[View Larger Version of this Image (10K GIF file)]


NMR Analysis of UDP-Galf

In order to unequivocally prove that p37 is UDP-Galf, about 1.5 mg of p37 was pooled from several HPLC runs on a semipreparative CarboPac PA1 (9 × 250 mm). After lyophilization, a small amount was redissolved in 100 mM ammonium acetate, pH 7.0, and analyzed by HPAEC. The material was found to be >95% pure (Fig. 6D) as judged by peak integration. During preparation of the sample for NMR analysis, the pH of the sample dropped below pH 6.0, which resulted in partial degradation of the nucleotide sugar. However, a complete assignment by two-dimensional methods of all proton, carbon, and phosphorous NMR resonances permitted the identification of intact p37 and of all the major components of the sample. By integration of the 1H spectrum, the sample was found to be a mixture of the following major components: 26% UDP-Galf, 53% 5'-UMP, and 21% Galf-1,2-P. The 1H spectrum is shown in Fig. 7, together with subspectra for the Galf moiety of UDP-Galf and Galf-1,2-P. The 1H-13C HMQC is shown in Fig. 8A along with the 1H and 13C spectra. The 1H-31P HMQC spectrum is shown in Fig. 8B, along with the 1H and 31P spectra. Proton, 13C and 31P chemical shifts are given in Tables II, III, IV. Coupling constants for 31P are in Table V and J(H,H) coupling constants in Table VI. Due to limited quantities of material, the low signal to noise in the 13C spectrum did not permit the measurement of J(C,P) couplings.


Fig. 7. Proton NMR-spectra of UDP-Galf and Galf-1,2-P. The 1H spectrum is shown in A. The sums of the one-dimensional TOCSY z-filtered spectra with a mixing time of 60 ms for selective excitation of the H1 and H4 resonances of the Galf residue in UDP-Galf (B) and for selective excitation of the H2 and H5 resonances of the Galf-1,2-P (C) are also shown.
[View Larger Version of this Image (18K GIF file)]



Fig. 8. NMR characterization of UDP-Galf and Galf-1,2-P. A, the 1H-13C HMQC spectrum along with the 13C spectrum and resolution enhanced 1H spectrum. The resonances for the Galf residue of UDP-Galf are labeled. B, the 1H-31P HMQC spectrum along with the 31P spectrum and the resolution enhanced 1H spectrum.
[View Larger Version of this Image (21K GIF file)]


Table II.

Proton chemical shifts

The spectrum was recorded at 285K in D2O, pH 6.8. EDTA resonances were at 1.913 and 3.675 ppm. Acetone was used as an internal chemical. Shift reference at 2.225 ppm. The HOD signal was at 4.945 ppm.
Compound Moiety H1 H2 H3 H4 H5 H5' H6 H6'

UDP-Galf Galf 5.629 4.152 4.238 3.823 3.76 3.629 3.711
Ribose 5.992 4.38 4.38 4.289 4.24 4.21
Ura 5.980 7.972
5'-UMP Ribose' 6.002 4.423 4.351 4.259 4.032 3.970
Ura' 5.970 8.141
Galf-1,2-P 6.000 4.813 4.404 3.975 3.894 3.745 3.639

Table III.

13C chemical shifts in ppm

The methyl resonance of an external acetone in D2O, set at 31.07 ppm, was used as the chemical shift reference. The 13C chemical shifts were obtained from an HMQC spectrum for the sample in D2O at pH 6.8, recorded at 285K. The EDTA resonances were at 24.1 and 58.0 ppm.
Compound Moiety C1 C2 C3 C4 C5 C6

UDP-Galf Galf 98.6 77.4 74.3 82.6 72.9 61.9
Ribose 89.1 74.6 70.5 84.1 65.7
Ura 103.5 142.4
5'-UMP Ribose' 89.1 74.7 70.9 84.9 64.0
Ura' 103.5 142.9
Galf-1,2-P 102.9 85.6 75.9 86.6 71.6 63.0

Table IV.

31P chemical shifts

The spectrum was recorded at 285K in D2O, pH 6.8. The chemical shift reference for 31P was that of external H3PO4 set at 0.0 ppm.
Compound Chemical shift

ppm
UDP-Galf  -11.2(forall ), -12.4(exist )
5'-UMP 3.5
Galf-1,2-P 17.1
(O4P)3- 1.7
(O3POPO3)4-  -7.9

Table V.

Spin-spin coupling constants (J) for 31P

The coupling constants for 5'-UMP are the same as previously reported.
Compound Spins J Spins J

Hz Hz
UDP-Galf Pforall , H5' 6 Pforall , H5" 5
Pexist , H1 5.5 Pexist , H2 2.3
Pforall , Pexist 21
Galf-1,2-P P, H1 14 P, H2 6.8

Table VI.

J(H,H) coupling constants in Hz for the Galf moiety

The coupling constants for the UDP moiety are the same as reported previously.
H1, H2 H2, H3 H3, H4 H4, H5 H5, H6 H5, H6' H6, H6'

UDP-Galf 4.3 8.6 7.6 5.2 4.3 7.2  -11.9
Galf-1,2-P 4.5 2.2 4.0 7.3 3.9 6.2  -11.9

UDP-Galf

The 31P spectrum showed the presence of various phosphorylated compounds, one of which contained a pyrophosphate group that has characteristic shifts at -11.2 ppm and -12.4 ppm and a J(Pforall ,Pexist ) coupling constant of 21 Hz (63). A 1H-31P HMQC spectrum indicated the proton resonances, which were coupled to the pyrophosphate group. The proton resonances at 5.629 ppm and 4.152 ppm, which were coupled to the 31P resonance at -12.4 ppm had J(P,H) coupling constants of 5.5 Hz and 2.3 Hz, respectively. The complete coupled spin system for these proton resonances was identified by COSY, TOCSY, and one-dimensional TOCSY experiments. The proton-proton coupling constants (J(H,H)) could be obtained from the one-dimensional TOCSY spectrum. A 1H-13C HMQC permitted the assignment of all the carbon atoms directly bonded to these protons (C-H). The proton chemical shifts, J(H,H) coupling constants, 13C chemical shifts (64), and 31P chemical shifts were all characteristic of a terminal alpha -Galf residue bonded to a pyrophosphate group.

From a similar analysis, the resonances at 4.24 and 4.21 ppm, which bonded to the pyrophosphate resonance at -11.2 ppm, were found to belong the H5' and H5" resonances of the ribose moiety of UDP-Galf. The proton chemical shifts, J(H,H) coupling constants, and J(P,H) coupling constants of the UDP moiety were found to be characteristic for those found for UDP sugars (65).

5'-UMP

In the 1H-31P HMQC spectrum, the 31P resonances at 3.5 ppm bonded to the proton resonances at 4.032 ppm and 3.970 ppm were found to belong to 5'-UMP by a complete assignment of the 1H and 13C spectra. The proton chemical shifts, J(H,H) coupling constants, and J(P,H) coupling constants of the 5'-UMP were found to be similar to those previously reported for this compound (66).

Galf-1,2-P

The 31P resonance at 17.1 ppm is characteristic of a five-membered cyclic ester (63). In the 1H-31P HMQC spectrum, this 31P resonance was coupled to the proton resonances at 6.000 ppm and 4.813 ppm, with J(P,H) coupling constants of 14 Hz and 6.8 Hz, respectively. From the assignment of the proton spin system for this residue obtained from the COSY and one-dimensional TOCSY experiment, the H1 and H2 resonances were found to be coupled to the cyclic phosphate.


DISCUSSION

Galactofuranosyl residues are found in a growing number of surface glycoconjugates from both Gram-negative and Gram-positive bacteria, as well as protozoa and fungi. These include well documented pathogens of humans and livestock. In bacteria (this work, and Refs. 44, 45, and 48) and fungi (46), the biosynthetic precursor for Galf residues is believed to be UDP-Galf. Galactofuranosyl-containing glycoconjugates have not been reported in humans so far, which makes UDP-Galf formation an interesting target for novel therapeutic compounds (38). However, development of strategies for inhibitors has been limited by the lack of fundamental information regarding the biosynthesis of galactofuranosyl residues. Galactocarolose, a beta -D-(1right-arrow5)-linked polygalactofuranosid produced by P. charlesii, was the first polysaccharide found to contain galactofuranosyl residues (34, 67). Trejo et al. (46) isolated a nucleotide sugar formed in cell-free enzyme preparations of P. charlesii, which was capable of acting as a donor of galactofuranosyl residues in the biosynthesis of a galactofuranosyl-containing polymer. Based on chemical analysis of the reaction products obtained by acid and alkaline hydrolosis as well as periodate oxidation, Trejo et al. (46) predicted that the sugar nucleotide is UDP-Galf. More recently, Nassau et al. (48) cloned the glf gene of E. coli and showed that it encodes UDP-galactopyranose mutase (EC 5.4.99.9). Nassau et al. (48) concluded that the reaction product of the UDP-galactopyranose mutase reaction is UDP-Galf based on HPLC analysis of the sugar 1-phosphate obtained after phosphodiesterase treatment of the reaction product. The modification of an HPAEC procedure, to give a method that separates UDP-Galp from UDP-Galf, allowed us for the first time to purify milligram quantities of UDP-Galf and to unequivocally prove by NMR the structure to be uridine 5'-(trihydrogen diphosphate) P'-alpha -D-galactofuranosyl ester. This will provide an essential reagent for biochemical analyses of synthetic systems for galactofuranosyl-containing glycoconjugates.

The data presented here establish that RfbDKPO1 catalyzes the interconversion of UDP-Galp and UDP-Galf. The LPS profiles of E. coli K-12 strains containing pWQ70 and pWQ71 clearly demonstrated that Glf (48) of E. coli can complement the rfbDKPO1 deletion in pWQ70. Glf and RfbDKPO1 are therefore functionally equivalent. Although the K. pneumoniae RfbDKPO1 protein shows 37.5% identity to Glf of E. coli, the two proteins do exhibit remarkable differences. Glf has been reported to be relatively unstable, resulting in complete loss of activity after storage of the purified protein at 4 °C for >24 h (48). In contrast, RfbDKPO1 can be stored at 4 °C for periods in excess of 1-2 weeks without significant loss of activity (data not shown). Moreover, no cofactor requirement other than FAD has been reported for Glf, while RfbDKPO1 has an absolute requirement for NADH or NADPH. These differences are difficult to explain. One possibility is that the binding constants for NADH (NADPH) are different in both proteins. Alternatively, the differences may be a result of the purification procedure used. Cibacron Blue 3GA used in the purification procedure reported here is thought to bind to NAD binding sites. Consequently, binding of the enzyme to this resin may displace the essential cofactor. Analysis of the predicted sequence of both proteins revealed a ADP-binding beta alpha beta -fold at its N terminus, which could be involved in binding FAD or NAD. The motif in K. pneumoniae differs at Gly-19 from the fingerprint. However, the known structure of p-hydroxybenzoate hydroxylase, which has a glycine at the same position (position 15 of the fingerprint), demonstrates that peptides with a glycine at this position can form a functional beta alpha beta unit (68). The presence of FAD in the purified Glf protein has been reported (48). Although we have not analyzed this cofactor in RfbDKPO1, the yellow color of the pure protein is consistent with its containing FAD. Gel filtration of the RfbDKPO1 protein on Superose 12 revealed a molecular weight of 92,000 for the native protein. The possible dimerization of Glf has not been investigated.

Little is known about the mechanism of the UDP-galactopyranose mutase (NAD(P)H-requiring) reaction. Stevenson et al. (47) suggested that the reaction may proceed via a 2-keto intermediate. Since in our hands the UDP-galactopyranose mutase reaction shows an absolute requirement for NADH or NADPH and was found to be inactive with NAD or NADP, an alternative is that the first step of the reaction may be a reduction step, although there is no net oxidation/reduction in the interconversion of UDP-Galp and UDP-Galf. The stability of the RfbDKPO1 protein and the possibility to synthesize and purify larger quantities of UDP-Galf will facilitate a detailed analysis of the reaction mechanism and determination of the protein structure.


FOOTNOTES

*   This work was supported by grants (to C. W.) from the Canadian Bacterial Diseases Network, one of the federal Networks of Centers of Excellence. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) L31762[GenBank] (for rfbCDEFKPO1).


   To whom correspondence and reprint requests should be addressed. Tel.: 519-837-4120 (ext. 3478); Fax: 519-837-1802; E-mail: cwhitfie{at}micro.uoguelph.ca.
1    The abbreviations used are: LPS, lipopolysaccharide; UDP-Galp or UDP-galactopyranose, uridine 5'-(trihydrogen diphosphate) P'-alpha -D-galactopyranosyl ester; UDP-Galf or UDP-galactofuranose, uridine 5'-(trihydrogen diphosphate) P'-alpha -D-galactofuranosyl ester; Galf-1,2-P, alpha -D-galactofuranose cyclic 1,2-(hydrogen phosphate); HPAEC, high performance anion exchange chromatography; COSY, correlated spectroscopy; TOCSY, total correlation spectroscopy; HMQC, heteronuclear multiple-quantum coherence; PAGE, polyacrylamide gel electrophoresis; S-LPS, smooth LPS; HPLC, high performance liquid chromatography.

Acknowledgments

We gratefully acknowledge the technical assistance provided by Karen Sutherland. We thank K. Duncan and colleagues for discussions and sharing data on glf prior to its publication.


Note Added in Proof

While this manuscript was in press, a report by others independently confirmed the nature and structure of UDP-Galf as the product of the UDP-galactopyranose mutase reaction (Lee, R., Monsey, D., Weston, A., Duncan, K., Rithner, C., and McNeil, M. (1996) Anal. Biochem. 242, 1-7).


REFERENCES

  1. Whitfield, C., Richards, J. C., Perry, M. B., Clarke, B. R., and MacLean, L. L. (1991) J. Bacteriol. 173, 1420-1431 [Medline] [Order article via Infotrieve]
  2. Kelly, R. F., Perry, M. B., MacLean, L. L., and Whitfield, C. (1995) J. Endotox. Res. 2, 131-140
  3. Kelly, R. F., Severn, W. B., Richards, J. C., Perry, M. B., McLean, L. L., Tomás, J. M., Merino, S., and Whitfield, C. (1993) Mol. Microbiol. 10, 615-625 [Medline] [Order article via Infotrieve]
  4. Whitfield, C., Perry, M. B., MacLean, L. L., and Yu, S. H. (1992) J. Bacteriol. 174, 4913-4919 [Abstract]
  5. Kol, O., Wieruszeski, J.-M., Strecker, G., Montreuil, J., Fournet, B., Zalisz, R., and Smets, P. (1991) Carbohydr. Res. 217, 117-125 [CrossRef][Medline] [Order article via Infotrieve]
  6. Kol, O., Wieruszeski, J.-M., Strecker, G., Fournet, B., Zalisz, R., and Smets, P. (1992) Carbohydr. Res. 236, 339-344 [CrossRef][Medline] [Order article via Infotrieve]
  7. Oxley, D., and Wilkinson, S. G. (1988) Carbohydr. Res. 172, 287-291 [CrossRef][Medline] [Order article via Infotrieve]
  8. Oxley, D., and Wilkinson, S. G. (1989) Carbohydr. Res. 193, 241-248 [CrossRef][Medline] [Order article via Infotrieve]
  9. Dmitriev, B. A., L'vov, V. L., and Kochetkov, N. K. (1977) Carbohydr. Res. 56, 207-209 [CrossRef][Medline] [Order article via Infotrieve]
  10. L'vov, V. L., Dashunin, V. M., Ramos, E. L., Shashkov, A. S., Dmitriev, B. A., and Kochetkov, N. K. (1983) Carbohydr. Res. 124, 141-149 [CrossRef][Medline] [Order article via Infotrieve]
  11. Jann, B., Shashkov, A. S., Kochanowski, H., and Jann, K. (1994) Carbohydr. Res. 264, 305-311 [Medline] [Order article via Infotrieve]
  12. Perry, M. B., and Babiuk, L. A. (1984) Can. J. Biochem. Cell Biol. 62, 108-114
  13. Altman, E., Brisson, J.-R., and Perry, M. B. (1988) Carbohydr. Res. 179, 245-258 [CrossRef][Medline] [Order article via Infotrieve]
  14. Perry, M. B. (1990) Biochem. Cell Biol. 68, 808-810 [Medline] [Order article via Infotrieve]
  15. Berst, M., Lüderitz, O., and Westphal, O. (1971) Eur. J. Biochem. 18, 361-368 [Medline] [Order article via Infotrieve]
  16. Abeygunawardana, C., Bush, C. A., and Cisar, J. O. (1991) Biochemistry 30, 8568-8577 [Medline] [Order article via Infotrieve]
  17. Abeygunawardana, C., Bush, C. A., and Cisar, J. O. (1991) Biochemistry 30, 6528-6540 [Medline] [Order article via Infotrieve]
  18. Abeygunawardana, C., Bush, C. A., and Cisar, J. O. (1990) Biochemistry 29, 234-248 [Medline] [Order article via Infotrieve]
  19. Bax, A., Summers, M. F., Egan, W., Guirgis, N., Schneerson, R., Robbins, J. B., Ørskov, F., Ørskov, I., and Vann, W. F. (1988) Carbohydr. Res. 173, 53-64 [CrossRef][Medline] [Order article via Infotrieve]
  20. Dutton, G. G. S., Parolis, H., and Parolis, L. A. S. (1985) Carbohydr. Res. 140, 263-275 [CrossRef][Medline] [Order article via Infotrieve]
  21. Besra, G. S., Khoo, K.-H., McNeil, M. R., Dell, A., Morris, H. R., and Brennan, P. J. (1995) Biochemistry 34, 4257-4266 [Medline] [Order article via Infotrieve]
  22. Daffe, M., McNeil, M., and Brennan, P. J. (1993) Carbohydr. Res. 249, 383-398 [CrossRef][Medline] [Order article via Infotrieve]
  23. Plackett, P., and Buttery, S. H. (1964) Biochem. J. 90, 201-205 [Medline] [Order article via Infotrieve]
  24. Christian, R., Schulz, G., Schuster-Kolbe, J., Allmaier, G., Schmid, E. R., Sleytr, U. B., and Messner, P. (1993) J. Bacteriol. 175, 1250-1256 [Abstract]
  25. Gerwig, G. J., de Waard, P., Kamerling, J. P., Vliegenthart, J. F. G., Morgenstern, E., Lamed, R., and Bayer, E. A. (1989) J. Biol. Chem. 264, 1027-1035 [Abstract/Free Full Text]
  26. Gerwig, G. J., Kamerling, J. P., Vliegenthart, J. F. G., Morag, E., Lamed, R., and Bayer, E. A. (1993) J. Biol. Chem. 268, 26956-26960 [Abstract/Free Full Text]
  27. Turco, S. J., Orlandi, P. A., Jr., Homans, S. W., Ferguson, M. A. J., Dwek, R. A., and Rademacher, T. W. (1989) J. Biol. Chem. 264, 6711-6715 [Abstract/Free Full Text]
  28. McConville, M. J., Thomas-Oates, J. E., Ferguson, M. A. J., and Homans, S. W. (1990) J. Biol. Chem. 265, 19611-19623 [Abstract/Free Full Text]
  29. Ilg, T., Etges, R., Overath, P., McConville, M. J., Thomas-Oates, J., Thomas, J., Homans, S. W., and Ferguson, M. A. J. (1992) J. Biol. Chem. 267, 6834-6840 [Abstract/Free Full Text]
  30. Mendelzon, D. H., and Parodi, A. J. (1986) J. Biol. Chem. 261, 2129-2133 [Abstract/Free Full Text]
  31. Previato, J. O., Gorin, P. A. J., Mazurek, M., Xavier, M. T., Fournet, B., Wieruszeski, J. M., and Mendonca-Previato, L. (1990) J. Biol. Chem. 265, 2518-2526 [Abstract/Free Full Text]
  32. Unkefer, C. J., and Gander, J. E. (1979) J. Biol. Chem. 254, 12131-12135 [Medline] [Order article via Infotrieve]
  33. Parra, E., Jiménez-Barbero, J., Bernabe, M., Leal, J. A., Prieto, A., and Gómez-Miranda, B. (1994) Carbohydr. Res. 257, 239-248 [CrossRef][Medline] [Order article via Infotrieve]
  34. Gorin, P. A. J., and Spencer, J. F. T. (1959) Can. J. Chem. 37, 499-502
  35. Takayanagi, T., Kimura, A., Chiba, S., and Ajisaka, K. (1994) Carbohydr. Res. 256, 149-158 [CrossRef][Medline] [Order article via Infotrieve]
  36. Nakajima, T., Yoshida, M., Nakamura, M., Hiura, N., and Matsuda, K. (1984) J. Biochem. (Tokyo) 96, 1013-1020 [Abstract]
  37. Barr, K., Laine, R. A., and Lester, R. L. (1984) Biochemistry 23, 5589-5596 [Medline] [Order article via Infotrieve]
  38. McNeil, M. R., and Brennan, P. J. (1991) Res. Microbiol. 142, 451-463 [CrossRef][Medline] [Order article via Infotrieve]
  39. Bronner, D., Clarke, B. R., and Whitfield, C. (1994) Mol. Microbiol. 14, 505-519 [Medline] [Order article via Infotrieve]
  40. Meier-Dieter, U., Barr, K., Starman, R., Hatch, L., and Rick, P. D. (1992) J. Biol. Chem. 267, 746-753 [Abstract/Free Full Text]
  41. Clarke, B. A., Bronner, D., Keenleyside, W. J., Severn, W. B., Richards, J. C., and Whitfield, C. (1995) J. Bacteriol. 177, 5411-5418 [Abstract]
  42. Clarke, B. R., and Whitfield, C. (1992) J. Bacteriol. 174, 4614-4621 [Abstract]
  43. Weikert, M. J., and Adhya, S. (1993) Mol. Microbiol. 10, 245-251 [Medline] [Order article via Infotrieve]
  44. Nikaido, H., and Sarvas, M. (1971) J. Bacteriol. 105, 1073-1082 [Medline] [Order article via Infotrieve]
  45. Sarvas, M., and Nikaido, H. (1971) J. Bacteriol. 105, 1063-1072 [Medline] [Order article via Infotrieve]
  46. Trejo, A. G., Chittenden, G. J. F., Buchanan, J. G., and Baddiley, J. (1970) Biochem. J. 117, 637-639 [Medline] [Order article via Infotrieve]
  47. Stevenson, G., Neal, B., Liu, D., Hobbs, M., Packer, N. H., Batley, M., Redmond, J. W., Lindquist, L., and Reeves, P. (1994) J. Bacteriol. 176, 4144-4156 [Abstract]
  48. Nassau, P. M., Martin, S. L., Brown, R. E., Weston, A., Monsey, D., McNeil, M. R., and Duncan, K. (1996) J. Bacteriol. 178, 1047-1052 [Abstract]
  49. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  50. Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994) Nucleic Acids Res. 22, 4673-4680 [Abstract]
  51. Deng, W. P., and Nickoloff, J. A. (1992) Anal. Biochem. 200, 81-88 [Medline] [Order article via Infotrieve]
  52. Hitchcock, P. J., and Brown, T. M. (1983) J. Bacteriol. 154, 269-277 [Medline] [Order article via Infotrieve]
  53. Lesse, A. J., Campagnari, A. A., Bittner, W. E., and Apicella, M. A. (1990) J. Immunol. Methods 126, 109-117 [CrossRef][Medline] [Order article via Infotrieve]
  54. Tsai, C.-M., and Frasch, C. E. (1982) Anal. Biochem. 119, 115-119 [Medline] [Order article via Infotrieve]
  55. Palmieri, M. J., Berry, G. T., Player, D. A., Rogers, S., and Segal, S. (1991) Anal. Biochem. 194, 388-393 [Medline] [Order article via Infotrieve]
  56. Baumann, H., Tzianabos, A. O., Brisson, J.-R., Kasper, D. L., and Jennings, H. J. (1992) Biochemistry 31, 4081-4089 [Medline] [Order article via Infotrieve]
  57. Uhrin, D., Brisson, J.-R., MacLean, L. L., Richards, J. C., and Perry, M. B. (1994) J. Biomol. NMR 4, 615-630 [Medline] [Order article via Infotrieve]
  58. Wierenga, R. K., Terpstra, P., and Hol, W. G. J. (1986) J. Mol. Biol. 187, 101-107 [Medline] [Order article via Infotrieve]
  59. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990) J. Mol. Biol. 215, 403-410 [CrossRef][Medline] [Order article via Infotrieve]
  60. Kelly, R. F., and Whitfield, C. (1996) J. Bacteriol. 178, 5205-5214 [Abstract]
  61. Yao, Z., and Valvano, M. A. (1994) J. Bacteriol. 176, 4133-4143 [Abstract]
  62. Fujita, K.-i., Maeda, K., Tanaka, T., Taniguchi, M., and Oi, S. (1993) Biosci. Biotech. Biochem. 57, 1166-1171
  63. Gorenstein, D. G. (1984) in Phosphorous-31 NMR: Principles and Applications (Gorenstein, D. G., ed), pp. 7-53, Academic Press, Inc., Orlando, FL
  64. Bock, K., Pedersen, C., and Pedersen, H. (1984) Adv. Carbohydr. Chem. Biochem. 42, 193-225
  65. Lee, C.-H., and Sarma, R. H. (1976) Biochemistry 15, 697-704 [Medline] [Order article via Infotrieve]
  66. Davies, D. B., and Danyluk, S. S. (1974) Biochemistry 13, 4417-4434 [Medline] [Order article via Infotrieve]
  67. Haworth, W. N., Raistrick, H., and Stacey, M. (1937) Biochem. J. 31, 640-644
  68. Wierenga, R. K., Drenth, J., and Schulz, G. E. (1983) J. Mol. Biol. 167, 725-739 [Medline] [Order article via Infotrieve]
  69. Neuhard, J., and Thomassen, E. (1976) J. Bacteriol. 126, 999-1001 [Medline] [Order article via Infotrieve]
  70. Kovach, M. E., Phillips, R. W., Elzer, P. H., Roop, R. M., II, and Peterson, K. M. (1994) BioTechniques 16, 800-802 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.